Anti-PD-L2 [366C.9E5]

Absolute Antibody

Anti-PD-L2 [366C.9E5]

7

This antibody has been used in the immunohistochemical detection of PD-L2 in formalin-fixed, paraffin-embedded tissue sections of Hodgkins lymphoma tissue sections (Ansell et al, 2018; Roemer et al, 2016), primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma biopsies (Shi et al, 2014; Chong et al, 2016), non-small-cell lung cancer tumour samples (Calles et al, 2015), primary and metastatic adenoid cystic carcinoma deposits (Sridharan et al, 2016), and tonsil and colorectal carcinoma tissue samples (Masugi et al, 2017).

ImmunoHistoChemistry

IHC

Research Use Only

Monoclonal

366C.9E5

PDCD1LG2

programmed cell death 1 ligand 2

B7 dendritic cell molecule; B7DC; B7-DC; bA574F11.2; Btdc; butyrophilin B7-DC; CD273; PD-1-ligand 2; PDCD1 ligand 2; PDCD1L2; PDL2; PD-L2; programmed cell death 1 ligand 2; programmed death ligand 2

Human

IgG1

Programmed cell death 1 ligand 2

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Human

This antibody was raised by immunising mice with a recombinant protein fragment corresponding to the extracellular domain of human PD-L2 (as an Ig fusion protein).

-20°C,2°C to 8°C

12352203